« Return to News | Study Conduct

Vince & Associates expands early phase gastrointestinal capabilities

Monday, August 26, 2013 12:20 PM

Vince & Associates Clinical Research, a provider of early phase clinical research services to the global biopharmaceutical industry, has expanded its capabilities in the gastrointestinal (GI) therapeutic area with the addition of a dedicated endoscopy suite at its Clinical Pharmacology Unit.

"Vince & Associates Clinical Research has successfully conducted a number of studies evaluating potential therapies in patients with gastrointestinal disorders. To supplement ongoing research, VACR has established an endoscopy suite to offer on-site access to a wide range of endoscopic procedures," said Dr. Brad Vince, chief executive officer and medical director.

The suite is equipped with advanced and minimally invasive video endoscopy technology from Olympus EndoTherapy. Procedures can be viewed remotely on a large screen and documented by video or still photography. The suite includes two sources of suction as well as resuscitation and medication stations to address patient safety and equipment is maintained at the purpose built disinfection station.

Vince & Associates has reached out to Summit Gastroenterology for its medical expertise to complement the new research capabilities. The board certified gastroenterologists have been asked to join the Vince & Associates’ clinical research team as investigators, bringing clinical experience as GI specialists.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.